Mankind Pharma draws rush of buy calls on 57 per cent jump since IPO

Mankind Pharma draws rush of buy calls on 57 per cent jump since IPO The company’s stock has surged 57 per cent since listing, driving its market value to more than $8 billion. It has already drawn nine buy ratings and one hold recommendation. That’s the most coverage in a similar span of time for an Indian stock that raised more than $500 million since November 2010. https://ift.tt/oYR7jeu